GAD1 and Alzheimer disease: Early expression of intraneuronal amyloid-β (not phospho-tau) and inflammatory and glycosylation pathway transcripts distinguish neocortical RORB+ and GAD1+ neurons selectively vulnerable to neurodegeneration in Alzheimer’s disease.